Detalles de la búsqueda
1.
Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease.
J Neurosci
; 31(10): 3926-34, 2011 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21389247
2.
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on ß-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
PLoS One
; 11(7): e0158205, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27421117
3.
Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model.
Int J Alzheimers Dis
; 20102010 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20862386
4.
AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice.
PLoS One
; 4(10): e7280, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19794916
Resultados
1 -
4
de 4
1
Próxima >
>>